News – Page 2 – Nang Kuang Medicine Trading Limited

Nang Kuang and biosyn Enter into an Exclusive Agreement to Commercialize Selenase ® in Chinese Mainland

In January 2023, Nang Kuang has entered into a long-term exclusive licensing partnership with biosyn Arzneimittel GmbH（biosyn）for the commercialization of Selenase ® (generic name: sodium Selenite Injection) for the treatment of selenium deficiency. biosyn Arzneimittel GmbH is a pharmaceutical and biotech company headquartered in Fellbach. biosyn specializes in trace elements, is a global market leader … Continue reading

Nang Kuang Partners with Orion to Commercialize Patented Inhalation Products in Mainland China Market

In December 2022, Nang Kuang has entered into a long-term exclusive licensing partnership with Orion Corporation（Orion）for the commercialization of Budesonide Inhalation Powder and Salbutamol Sulfate Inhalation Powder. Orion is a globally operating Finnish pharmaceutical company founded in 1917. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is a … Continue reading

Nang Kuang and Esteve Enter into an Exclusive Agreement about Pain Management Products in Mainland China Market

In December 2023, Nang Kuang has entered into a long-term exclusive co-development and licensing partnership with Esteve Pharmaceutical（Esteve）for R&D and commercialization of patented products for pain management. Esteve Pharmaceutical is the top pharmaceutical company in Spain. Founded in 1929 and headquartered in Barcelona, Spain, Esteve’s business covers the entire spectrum of R&D and manufacture, including … Continue reading

Nang Kuang Partners with Chanelle to Commercialize Vardenafil Orodispersible Tablets in China and UK Markets

BEIJING Oct. 25，2023—-Nang Kuang has entered into a long-term exclusive distributing partnership with Chanelle Pharma (Chanelle) for the commercialization of Vardenafil Orodispersible 10mg Tablets for the treatment of erectile dysfunction. Vardenafil 10 mg Orodispersible Tablets is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain … Continue reading